Kimura T, Ogura F, Yamamoto K, Uda A, Nishioka T, Kume M, Makimoto H, Yano I, Hirai M
Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
J Clin Pharm Ther. 2017 Apr;42(2):209-214. doi: 10.1111/jcpt.12496. Epub 2016 Dec 31.
The Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (stopp) criteria were updated in 2014 (stopp criteria ver.2), but few studies have evaluated the usefulness of stopp criteria in elderly patients. This prospective observational study evaluated the prevalence of potentially inappropriate medications (PIMs), and the efficacy of hospital pharmacists' assessment and intervention based on stopp criteria ver.2.
The study was conducted at three medical units of Kobe University Hospital between April 2015 and March 2016. Pharmacists assessed and detected PIMs based on stopp criteria ver.2 and considered the patient's intention to change the prescription at the time of admission of each patient. If the pharmacists judged that benefits outweighed risks of prescription change and the patients consented to change the medications, they recommended the doctor to change the prescription. If there was a risk of exacerbation of disease by the change of medications and the pharmacists judged it to be difficult to adjust medications during hospitalization or the patients did not consent to change the medications, they did not recommend to change it. The pharmacists and the doctors discussed and finally decided whether to change the PIMs or not. The number of patients prescribed PIMs, the number and contents of PIMs, and the number of medications changed after pharmacists' intervention were calculated.
Totally, 822 new inpatients aged ≥65 years prescribed ≥1 daily medicine were included. Their median (interquartile range) age was 75·0 (71·0-80·0) years, and 54·9% were male. According to the criteria, 346 patients (42·1%) were prescribed ≥1 PIMs. Patients prescribed PIMs took significantly more medications than others: 10·0 (7·0-13·0) vs. 6·0 (4·0-9·0), P < 0·001. The total number of PIMs was 651%, 47·6% of which (n = 310) were recommended the doctors to change, and 292 of 651 PIMs (44·9%) were finally discontinued/changed after pharmacists' assessment and intervention. PIMs related to benzodiazepines, including Z-drugs, were most frequent, with a detailed classifications as follows (changed/total): (i) benzodiazepines for 4 or more weeks (75/205), (ii) drugs that predictably increase the risk of falls in older people (benzodiazepines) (30/67) and (iii) drugs that predictably increase the risk of falls in older people (hypnotic Z-drugs) (15/31).
Over 40% elderly patients were prescribed PIMs, and pharmacists' assessments and interventions based on stopp criteria ver.2 were useful in detecting and correcting prescription of PIMs.
老年人潜在不适当处方筛查工具(STOPP)标准于2014年进行了更新(STOPP标准第2版),但很少有研究评估STOPP标准在老年患者中的实用性。这项前瞻性观察性研究评估了潜在不适当用药(PIM)的发生率,以及基于STOPP标准第2版的医院药师评估和干预的效果。
该研究于2015年4月至2016年3月在神户大学医院的三个医疗科室进行。药师根据STOPP标准第2版评估并检测PIM,并在每位患者入院时考虑患者改变处方的意愿。如果药师判断改变处方的益处大于风险且患者同意改变用药,他们会建议医生改变处方。如果改变用药有疾病加重的风险,且药师判断在住院期间难以调整用药或患者不同意改变用药,他们则不建议改变。药师和医生进行讨论并最终决定是否改变PIM。计算了开具PIM的患者数量、PIM的数量和内容,以及药师干预后改变的用药数量。
总共纳入了822名年龄≥65岁且每天开具≥1种药物的新住院患者。他们的年龄中位数(四分位间距)为75.0(71.0 - 80.0)岁,男性占54.9%。根据标准,346名患者(42.1%)开具了≥1种PIM。开具PIM的患者服用的药物明显多于其他人:10.0(7.0 - 13.0)种对6.0(4.0 - 9.0)种,P < 0.001。PIM的总数为651种,其中47.6%(n = 310)被建议医生改变,651种PIM中有292种(44.9%)在药师评估和干预后最终停药/改变。与苯二氮䓬类相关的PIM,包括Z类药物,最为常见,具体分类如下(改变/总数):(i)使用4周或更长时间的苯二氮䓬类药物(75/205),(ii)可预测增加老年人跌倒风险的药物(苯二氮䓬类)(30/67),以及(iii)可预测增加老年人跌倒风险的药物(催眠Z类药物)(15/31)。
超过40%的老年患者开具了PIM,基于STOPP标准第2版的药师评估和干预在检测和纠正PIM处方方面是有用的。